Megan Balaisius
About Megan Balaisius
Megan Balaisius is the R&D Strategy Implementation Lead at Bristol Myers Squibb with over 15 years of experience in the pharmaceutical and biotechnology industries.
Title at Bristol Myers Squibb
Megan Balaisius currently holds the position of R&D Strategy Implementation Lead at Bristol Myers Squibb. She joined the company in August 2020 and brings over 15 years of experience in the pharmaceutical and biotechnology industries to her role.
Experience in Pharmaceutical Industry
Megan Balaisius has accumulated over 15 years of experience working with major pharmaceutical companies. Her career includes significant roles at Celgene, Novo Nordisk A/S, Novartis, and Beardsworth. Throughout her various positions, she has demonstrated a strong background in clinical project management, leadership, and regulatory compliance.
Past Roles at Celgene
Before joining Bristol Myers Squibb, Megan Balaisius worked at Celgene. She served as Director Project Leadership from 2019 to 2020, and prior to that, as Associate Director Project Leadership from 2017 to 2019. During her tenure, she played a crucial role in leading project teams and implementing R&D strategies.
Education and Academic Background
Megan Balaisius achieved her MBA from Rutgers Business School, graduating between 2007 and 2011. She also holds a Bachelor of Science in Biology from The College of New Jersey. Her academic credentials have equipped her with a solid foundation for her career in the pharmaceutical and biotechnology sectors.
Expertise in Clinical Project Management
Throughout her career, Megan Balaisius has developed significant expertise in managing clinical trials and ensuring regulatory compliance. Her work has involved successfully leading cross-functional teams and implementing strategic initiatives in the R&D sector. This experience has been instrumental in her current role as R&D Strategy Implementation Lead at Bristol Myers Squibb.